| Name | Title | Contact Details |
|---|
Permobil founder Dr. Per Uddén believed that helping individuals achieve the greatest level of independence is a basic human right and, for over 50 years, that has been the driving force behind our innovative assistive technology. We are passionate about understanding our users` needs and helping them live life to the fullest. We are a global leader in trusted healthcare solutions for power and manual wheelchairs, seating and positioning products, and power assist. Permobil is part of Patricia Industries, a subsidiary of Investor AB and is headquartered in Sweden. Permobil has 1600 team members in more than 15 countries around the world. For more information regarding the company`s storied history and complete product line visit permobil.com. Permobil Group is owned by Investor AB and the global leader in Advanced Rehab Technology. We are present in more than 17 countries with 1 600 employees and have an annual turnover of more than SEK 4 billion. Our major brands are Permobil, TiLite and ROHO, with more to come. We are continuously growing by entering new geographical markets and adding new technologies and products, to further support the community of people with disabilities.
KoKo, LLC is a global respiratory information systems software developer and medical device manufacturing company. The exclusive provider of Iris™, the world`s first Integrated Respiratory Information System; and KoKo® pulmonary function testing, diagnostic spirometry, and respiratory home monitoring devices. Our expert, scalable software solutions and sophisticated data collection products empower healthcare providers to advance respiratory diagnostic processes and improve patient outcomes while meeting the demanding clinical and business objectives of thought leaders in respiratory care.
Ogi Frames Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
Qserve America is a Claremont, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.